Elias Eckert serves as the Senior Director of Portfolio Management at BioNTech SE since August 2022, leading cross-functional teams to advance individualized mRNA-based cancer therapies. Previously, as Director of Portfolio Management at EY-Parthenon from September 2018 to August 2022, Elias focused on strategy projects in the Life Science sector, with specialties in cell and gene therapy, oncology, and diagnostics. Earlier roles include Senior Consultant at DKFZ German Cancer Research Center and co-founder of the N² Network. Elias’s academic background includes a Doctorate in Stem Cell Biology and Gene Therapy from DKFZ, a Master of Science in Cellular and Molecular Biology from Heidelberg University, and a Bachelor of Science in Biochemistry from the University of Regensburg.
This person is not in any teams
This person is not in any offices